Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 48, 2019 - Issue 6
Submit an article Journal homepage
411
Views
7
CrossRef citations to date
0
Altmetric
Articles

Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study

LM VerhoefDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The NetherlandsCorrespondence[email protected]
,
DPG BosDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands
,
CHM van den EndeDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands;Department of Rheumatology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
,
FHJ van den HoogenDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands;Department of Rheumatology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
,
B FautrelAP-HP, Rheumatology Department, Pitié-Salpêtrièe Hospital, Paris, France
,
ME HulscherIQ healthcare, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
,
W KievitDepartment for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
&
AA den BroederDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands;Department of Rheumatology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
 show all
Pages 439-447 | Accepted 28 Apr 2019, Published online: 21 Jun 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

D Bertrand, V Stouten, D De Cock, S Pazmino, M Doumen, I de Wergifosse, J Joly, V Badot, L Corluy, I Hoffman, V Taelman, K De Knop, E Geens, C Langenaken, JL Lenaerts, J Lenaerts, M Walschot, J Mannaerts, R Westhovens & P Verschueren. (2022) Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial. Scandinavian Journal of Rheumatology 51:6, pages 470-480.
Read now

Articles from other publishers (6)

Matthijs S. van der Leeuw, Marianne A. Messelink, Janneke Tekstra, Ojay Medina, Jaap M. van Laar, Saskia Haitjema, Floris Lafeber, Josien J. Veris-van Dieren, Marlies C. van der Goes, Alfons A. den Broeder & Paco M. J. Welsing. (2022) Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions. Arthritis Research & Therapy 24:1.
Crossref
Marianne A. Messelink, Matthijs S. van der Leeuw, Alfons A. den Broeder, Janneke Tekstra, Marlies C. van der Goes, Marloes W. Heijstek, Floris Lafeber & Paco M. J. Welsing. (2022) Prediction Aided Tapering In rheumatoid arthritis patients treated with biOlogicals (PATIO): protocol for a randomized controlled trial. Trials 23:1.
Crossref
L Terslev, Mikkel Ostergaard, Stylianos Georgiadis, Cecilie Heegaard Brahe, Karen Ellegaard, UM Dohn, Viktoria Fana, Torsten Møller, Lars Juul, Tuan Khai Huynh, Simon Krabbe, L M Ornbjerg, Daniel Glinatsi, Henrik Røgind, Annette Hansen, Jesper Nørregaard, Søren Jacobsen, Dorte V Jensen, Natalia Manilo, Karsten Asmussen, Mikael Boesen, Zoreh Rastiemadabadi, Lone Morsel-Carlsen, Jakob Møllenbach Møller, Niels Steen Krogh & Merete Lund Hetland. (2022) Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors. RMD Open 8:2, pages e002796.
Crossref
Glen S. Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, Orit Schieir, Claire E.H. Barber, Laurie Proulx, Dawn P. Richards, Peter Tugwell, Nick Bansback, Pooneh Akhavan, Claire Bombardier, Vivian Bykerk, Shahin Jamal, Majed Khraishi, Regina Taylor-Gjevre, J. Carter Thorne, Arnav Agarwal & Janet E. Pope. (2022) Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs. The Journal of Rheumatology 49:10, pages 1092-1099.
Crossref
Tomohiro Hirose, Isao Kawaguchi, Tatsunori Murata & Tatsuya Atsumi. (2022) Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment With Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan. Value in Health Regional Issues 28, pages 105-111.
Crossref
Safaa Fellous, Hanan Rkain, Samir Ahid, Redouane Abouqal, Latifa Tahiri, Ihsane Hmamouchi, Lahsen Achemlal, Imane El Bouchti, Abdellah El Maghraoui, Imad Ghozlani, Hasna Hassikou, Taoufik Harzy, Linda Ichchou, Ouafa Mkinsi, Radouane Niamane, Rachid Bahiri & Fadoua Allali. (2021) One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry. Rheumatology International 41:4, pages 787-793.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.